Financial Architects (New Jersey)’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-100
| Closed | -$5K | – | 1370 |
|
|
2018
Q3 | $5K | Buy |
+100
| New | +$5K | ﹤0.01% | 1095 |
|
|
2018
Q2 | – | Sell |
-1,400
| Closed | -$43K | – | 1442 |
|
|
2018
Q1 | $43K | Buy |
1,400
+350
| +33% | +$10.8K | 0.01% | 579 |
|
|
2017
Q4 | $19K | Hold |
1,050
| – | – | ﹤0.01% | 857 |
|
|
2017
Q3 | $12K | Sell |
1,050
-5,000
| -83% | -$57.1K | ﹤0.01% | 991 |
|
|
2017
Q2 | $22K | Hold |
6,050
| – | – | ﹤0.01% | 832 |
|
|
2017
Q1 | $31K | Hold |
6,050
| – | – | 0.01% | 727 |
|
|
2016
Q4 | $29K | Hold |
6,050
| – | – | 0.01% | 729 |
|
|
2016
Q3 | $40K | Hold |
6,050
| – | – | 0.01% | 639 |
|
|
2016
Q2 | $33K | Buy |
6,050
+1,050
| +21% | +$5.73K | 0.01% | 644 |
|
|
2016
Q1 | $107K | Buy |
+5,000
| New | +$107K | 0.04% | 261 |
|
|
2015
Q3 | – | Sell |
-5,000
| Closed | -$157K | – | 948 |
|
|
2015
Q2 | $157K | Hold |
5,000
| – | – | 0.06% | 230 |
|
|
2015
Q1 | $147K | Buy |
5,000
+2,000
| +67% | +$58.8K | 0.06% | 237 |
|
|
2014
Q4 | $56K | Hold |
3,000
| – | – | 0.02% | 331 |
|
|
2014
Q3 | $53K | Buy |
+3,000
| New | +$53K | 0.03% | 303 |
|